# 510K SUMMARY

# This summary of $5 1 0 ( k )$ safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

The assigned 510(k) number is: k062204

# COMPANY/CONTACT PERSON

Seradyn, Inc   
7998 Georgetown Road, Suite 1000   
Indianapolis, IN 46268

Establishment registration No: 1836010

Earl E. Knight III, MPA Regulatory Affairs Associate Telephone: (317) 554-0639 Fax: (317) 610-0018

# DATE PREPARED

July 27, 2006

# DEVICE NAME

Trade Name: Common Name: Device Classification:

ARCHITECT Cortisol   
Fluorometric, Cortisol   
21 CFR 862.1205; Cortisol (hydrocortisone and hydroxycorticosterone) test   
system; Class II

Trade Name: Common Name: Device Classification:

ARCHITECT Cortisol Calibrators   
Calibrator, Secondary   
21 CFR 862.1150; Cortisol (calibrator) test system; Class II

# Intended use

ARCHITECT® Cortisol is a chemiluminescent microparticle mmunoassay (CMIA) for the quantitative determination of cortisol in human serum, plasma or urine on the ARCHITECT / System.The ARCHITECT Cortisol assay is intended for use as an aid in the diagnosis and treatment of adrenal disorders.

TRCHITEC Co r    RCHITC shuse quantitative determination of cortisol in human serum, plasma or urine.

# Legally marketed device to which equivalency is claimed

AXSYM® CORTISOL REAGENTS AND CALIBRATORS (K033731)

DESCRIPTION OF DEVICE

The ARCHITECT Cortisol assay is a delayed one-step immunoassay for the quantitative determination of col in human seru plas  rieusiMA tenology wi flexible assay protocols, referre  s Chemiflex.

# COMPARISON OF TECHNOLOGICAL CHARACTERISTICS

<table><tr><td rowspan=1 colspan=1>DeviceARCHITECT Cortisol</td><td rowspan=1 colspan=1>PredicateAxSYM Cortisol</td></tr><tr><td rowspan=1 colspan=1>IntendedUse(Reagents)</td><td rowspan=1 colspan=1>ARCHITECT Cortisol is a chemiluminescentmicroparticle immunoassay (CMIA) for thequantitative determination of cortisol inhuman serum, plasma or urine on theARCHITECT / System. The ARCHITECTCortisol assay is intended for use as an aid inthe diagnosis and treatment of adrenaldisorders.</td><td rowspan=1 colspan=1>The Cortisol assay is a FluorescencePolarization Immunoassay (FPIA) for thequantitative measurement of cortisol inhuman serum, plasma and urine on theAxSYM System to aid in the diagnosis andtreatment of adrenal disorders.</td></tr><tr><td rowspan=1 colspan=1>IntendedUse(Calibrators)</td><td rowspan=1 colspan=1>The ARCHITECT® Cortisol Calibrators arefor the calibration of the ARCHITECT iSystem when used for the quantitativedetermination of cortisol in human serum,plasma or urine.</td><td rowspan=1 colspan=1>The AxSYM Cortisol Calibrators are for thecalibration of the Abbott AxSYM CortisolSystem to aid in the diagnosis andtreatment of adrenal disorders.</td></tr><tr><td rowspan=1 colspan=1>Indicationsfor Use</td><td rowspan=1 colspan=1>The results obtained are used to aiddiagnosis and treatment of adrenal disorders.</td><td rowspan=1 colspan=1>The results obtained are used to aiddiagnosis and treatment of adrenaldisorders.</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Heterogeneous chemiluminescentmicroparticle immunoassay (CMIA).</td><td rowspan=1 colspan=1>Fluorescence Polarization Immunoassay(FPIA) technology.</td></tr><tr><td rowspan=1 colspan=1>ReagentComponents</td><td rowspan=1 colspan=1>Two (2) reagent system:•       Microparticle Reagent with Anti-Cortisol (mouse) coated Microparticles inbuffer with protein stabilizer, Proclin 300and sodium azide.Conjugate Reagent with Cortisolacridinium labeled conjugate in buffer withsurfactant stabilizer and Proclin 300.</td><td rowspan=1 colspan=1>Three (3) reagent system:.       Pretreatment Solution (P)Surfactant in TRIS buffer and sodiumazide.Cortisol Antiserum (Mouse andGoat) in buffer with protein stabilizerand Sodium azide.Cortisol Fluorescein Tracer inbuffer containing surfactant andstabilizers, and Sodium azide.</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>ARCHITECT Cortisol Calibrators - six levels</td><td rowspan=1 colspan=1>AxSYM Cortisol Calibrators - six levels</td></tr></table>

# SUMMARY OF CLINICAL TESTING

# Linearity

Linearity by Dilution was determined by a study based on the NCCLS guideline EP6-A: Evaluation of the Linearity of Quantitative Measurement.

A regression analysis plot of recovered cortisol against dilution factor was constructed. The p-values and regression standard error (Reg SE) were examined for each pool. The second order polynomial regression was chosen and the percent deviation from linearity (%DLP) calculated from the predicted second order polynomial regression and compared to the predicted first order polynomial (linear) regression.

65 ug/dL Serum Pool   

<table><tr><td rowspan=1 colspan=1>Dilution</td><td rowspan=1 colspan=1>Resultug/dL</td><td rowspan=1 colspan=1>Predicted1stug/dL</td><td rowspan=1 colspan=1>Predicted2ndug/dL</td><td rowspan=1 colspan=1>differenceug/dL</td><td rowspan=1 colspan=1>% DLP</td></tr><tr><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>90%</td><td rowspan=1 colspan=1>65.85</td><td rowspan=1 colspan=1>64.60</td><td rowspan=1 colspan=1>66.17</td><td rowspan=1 colspan=1>-1.6</td><td rowspan=1 colspan=1>-2%</td></tr><tr><td rowspan=1 colspan=1>80%</td><td rowspan=1 colspan=1>58.41</td><td rowspan=1 colspan=1>57.28</td><td rowspan=1 colspan=1>57.80</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-1%</td></tr><tr><td rowspan=1 colspan=1>70%</td><td rowspan=1 colspan=1>49.69</td><td rowspan=1 colspan=1>49.96</td><td rowspan=1 colspan=1>49.70</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>60%</td><td rowspan=1 colspan=1>41.92</td><td rowspan=1 colspan=1>42.64</td><td rowspan=1 colspan=1>41.85</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>33.69</td><td rowspan=1 colspan=1>35.31</td><td rowspan=1 colspan=1>34.27</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>40%</td><td rowspan=1 colspan=1>26.74</td><td rowspan=1 colspan=1>27.99</td><td rowspan=1 colspan=1>26.95</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>4%</td></tr><tr><td rowspan=1 colspan=1>30%</td><td rowspan=1 colspan=1>19.72</td><td rowspan=1 colspan=1>20.67</td><td rowspan=1 colspan=1>19.89</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>4%</td></tr><tr><td rowspan=1 colspan=1>20%</td><td rowspan=1 colspan=1>14.02</td><td rowspan=1 colspan=1>13.35</td><td rowspan=1 colspan=1>13.09</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>10%</td><td rowspan=1 colspan=1>6.53</td><td rowspan=1 colspan=1>6.03</td><td rowspan=1 colspan=1>6.55</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-8%</td></tr><tr><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>-0.04</td><td rowspan=1 colspan=1>-1.30</td><td rowspan=1 colspan=1>0.27</td><td rowspan=1 colspan=1>-1.6</td><td rowspan=1 colspan=1>Target+20%Deviationall</td></tr></table>

8 ug/dL Serum Pool   

<table><tr><td rowspan=1 colspan=1>Dilution</td><td rowspan=1 colspan=1>Resultug/dL</td><td rowspan=1 colspan=1>Predicted1stug/dL</td><td rowspan=1 colspan=1>Predicted2ndug/dL</td><td rowspan=1 colspan=1>differenceug/dL</td><td rowspan=1 colspan=1>% DLP</td></tr><tr><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>7.79</td><td rowspan=1 colspan=1>7.66</td><td rowspan=1 colspan=1>7.81</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>-2%</td></tr><tr><td rowspan=1 colspan=1>90%</td><td rowspan=1 colspan=1>7.01</td><td rowspan=1 colspan=1>6.86</td><td rowspan=1 colspan=1>6.92</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-1%</td></tr><tr><td rowspan=1 colspan=1>80%</td><td rowspan=1 colspan=1>5.87</td><td rowspan=1 colspan=1>6.07</td><td rowspan=1 colspan=1>6.06</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>70%</td><td rowspan=1 colspan=1>5.27</td><td rowspan=1 colspan=1>5.27</td><td rowspan=1 colspan=1>5.21</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>60%</td><td rowspan=1 colspan=1>4.43</td><td rowspan=1 colspan=1>4.48</td><td rowspan=1 colspan=1>4.39</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>3.68</td><td rowspan=1 colspan=1>3.69</td><td rowspan=1 colspan=1>3.58</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>40%</td><td rowspan=1 colspan=1>2.83</td><td rowspan=1 colspan=1>2.89</td><td rowspan=1 colspan=1>2.80</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>30%</td><td rowspan=1 colspan=1>2.03</td><td rowspan=1 colspan=1>2.10</td><td rowspan=1 colspan=1>2.04</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>20%</td><td rowspan=1 colspan=1>1.16</td><td rowspan=1 colspan=1>1.30</td><td rowspan=1 colspan=1>1.29</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>10%</td><td rowspan=1 colspan=1>0.49</td><td rowspan=1 colspan=1>0.51</td><td rowspan=1 colspan=1>0.57</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-12%</td></tr><tr><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>-0.01</td><td rowspan=1 colspan=1>-0.28</td><td rowspan=1 colspan=1>-0.13</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>Target± 20%Deviation</td></tr></table>

# Accuracy

Accuracy by Recovery was determined by spiking cortisol into human serum and urine to achieve concentrations across the range of the assay. The samples were analyzed in triplicate with the ARCHITECT Cortisol assay.

Serum   

<table><tr><td rowspan=2 colspan=1></td><td rowspan=1 colspan=3>Donor 1</td><td rowspan=1 colspan=3>Donor 2</td><td rowspan=1 colspan=3>Donor 3</td></tr><tr><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>%Recovery</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>%Recovery</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>% Recovery</td></tr><tr><td rowspan=1 colspan=1>Unspiked</td><td rowspan=1 colspan=1>8.1</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>13.7</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>12.6</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Spiked5 ugL</td><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>12.7</td><td rowspan=1 colspan=1>98.5</td><td rowspan=1 colspan=1>17.8</td><td rowspan=1 colspan=1>18.2</td><td rowspan=1 colspan=1>97.6</td><td rowspan=1 colspan=1>16.4</td><td rowspan=1 colspan=1>17.1</td><td rowspan=1 colspan=1>95.7</td></tr><tr><td rowspan=1 colspan=1>Spiked10 ug/dL</td><td rowspan=1 colspan=1>15.7</td><td rowspan=1 colspan=1>17.3</td><td rowspan=1 colspan=1>90.9</td><td rowspan=1 colspan=1>21.2</td><td rowspan=1 colspan=1>22.8</td><td rowspan=1 colspan=1>93.2</td><td rowspan=1 colspan=1>20.4</td><td rowspan=1 colspan=1>21.7</td><td rowspan=1 colspan=1>94.1</td></tr><tr><td rowspan=1 colspan=1>Spiked20 ug/dL</td><td rowspan=1 colspan=1>23.7</td><td rowspan=1 colspan=1>26.4</td><td rowspan=1 colspan=1>89.6</td><td rowspan=1 colspan=1>28.7</td><td rowspan=1 colspan=1>31.8</td><td rowspan=1 colspan=1>90.2</td><td rowspan=1 colspan=1>28.4</td><td rowspan=1 colspan=1>30.8</td><td rowspan=1 colspan=1>92.3</td></tr><tr><td rowspan=1 colspan=1>Spiked40 ug/dL</td><td rowspan=1 colspan=1>39.5</td><td rowspan=1 colspan=1>44.8</td><td rowspan=1 colspan=1>88.2</td><td rowspan=1 colspan=1>43.0</td><td rowspan=1 colspan=1>49.9</td><td rowspan=1 colspan=1>86.1</td><td rowspan=1 colspan=1>43.2</td><td rowspan=1 colspan=1>48.9</td><td rowspan=1 colspan=1>88.3</td></tr></table>

Urine   

<table><tr><td rowspan=2 colspan=1></td><td rowspan=1 colspan=3>Donor 1</td><td rowspan=1 colspan=3>Donor 2</td><td rowspan=1 colspan=3>Donor 3</td></tr><tr><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>%Recovery</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>%Recovery</td><td rowspan=1 colspan=1>Observed</td><td rowspan=1 colspan=1>Expected</td><td rowspan=1 colspan=1>% Recovery</td></tr><tr><td rowspan=1 colspan=1>Unspiked</td><td rowspan=1 colspan=1>5.7</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>22.0</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>11.9</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Spiked5 ug/dL</td><td rowspan=1 colspan=1>10.4</td><td rowspan=1 colspan=1>10.3</td><td rowspan=1 colspan=1>100.9</td><td rowspan=1 colspan=1>25.1</td><td rowspan=1 colspan=1>26.4</td><td rowspan=1 colspan=1>94.9</td><td rowspan=1 colspan=1>16.1</td><td rowspan=1 colspan=1>16.4</td><td rowspan=1 colspan=1>97.9</td></tr><tr><td rowspan=1 colspan=1>Spiked10 ug/dL</td><td rowspan=1 colspan=1>14.0</td><td rowspan=1 colspan=1>14.9</td><td rowspan=1 colspan=1>93.8</td><td rowspan=1 colspan=1>29.5</td><td rowspan=1 colspan=1>30.9</td><td rowspan=1 colspan=1>95.5</td><td rowspan=1 colspan=1>19.3</td><td rowspan=1 colspan=1>21.0</td><td rowspan=1 colspan=1>91.9</td></tr><tr><td rowspan=1 colspan=1>Spiked20 ug/dL</td><td rowspan=1 colspan=1>22.2</td><td rowspan=1 colspan=1>24.1</td><td rowspan=1 colspan=1>92.0</td><td rowspan=1 colspan=1>34.6</td><td rowspan=1 colspan=1>39.8</td><td rowspan=1 colspan=1>87.0</td><td rowspan=1 colspan=1>27.6</td><td rowspan=1 colspan=1>30.1</td><td rowspan=1 colspan=1>91.7</td></tr><tr><td rowspan=1 colspan=1>Spiked40 ug/dL</td><td rowspan=1 colspan=1>36.0</td><td rowspan=1 colspan=1>42.6</td><td rowspan=1 colspan=1>84.6</td><td rowspan=1 colspan=1>52.0</td><td rowspan=1 colspan=1>57.6</td><td rowspan=1 colspan=1>90.3</td><td rowspan=1 colspan=1>41.2</td><td rowspan=1 colspan=1>48.3</td><td rowspan=1 colspan=1>85.3</td></tr></table>

# Sensitivity

)The limit of blank (LoB) and the LoD were determined with guidance from CLSI guideline NCCLS EP17- Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline using proportions of false positives $\langle \alpha \rangle$ less than $5 \%$ and false negatives (β) less than $5 \%$ .These determinations were performed using 60 blank and 120 low level samples.

ARCHITECT i2000 EY $\mathsf { L o B } = 0 . 2 3 4 ~ \mu \mathsf { g } / \mathsf { d L }$ and LoD= 0.401ug/dL ARCHITECT i2000SR $\mathsf { L o B } \mathrm { = } 0 . 1 2 5 \ \mathsf { \mu g / d L }$ and LoD= 0.255ug/dL

An assay claim of $\scriptstyle \mathtt { L o D = 0 . 8 u g / d L }$ is supported by the data.

)The functional sensitivity of the ARCHITECT Cortisol assay was determined with guidance from CLSI guideline NCCLS EP17-A.

At the upper $9 5 \%$ confidence limit, the lowest serum value exhibiting a $20 \%$ CV was calculated to be $0 . 8 \mu \ g / \ d L$ . At the upper $9 5 \%$ confidence limit, the lowest urine value exhibiting a $20 \%$ CV was calculated to be $1 \mu \ g / \ d L$ .

# Method Comparison

The studies were conducted according to CLSI Guideline NCCLS EP9: Method Comparison and Bias Estimation Using Patient Samples to compare accuracy of recovery of Cortisol in serum and urine assayed by the ARCHITECT Cortisol assay to the Abbott $\mathsf { A x S Y M } ^ { \mathfrak { E } }$ Cortisol assay.

The results of the Method comparison study met the design goals and acceptance criteria.

# Precision

A precision study was performed using the National Committe or Clinical Laboratory Standards (NCCLS) guideline 5-A: Evaluation of Precision Performance o Clinical Chemistry Devices.   

<table><tr><td rowspan=2 colspan=1>Sample</td><td rowspan=2 colspan=1>Instr.</td><td rowspan=2 colspan=1>Reagent Lot</td><td rowspan=2 colspan=1>n</td><td rowspan=2 colspan=1>MeanConc.ug/dL</td><td rowspan=1 colspan=2>Within Run</td><td rowspan=1 colspan=2>Between Day</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=2 colspan=1>MCC 1</td><td rowspan=1 colspan=1>12000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.1369</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>0.1315</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>0.1898</td><td rowspan=1 colspan=1>5.0</td></tr><tr><td rowspan=1 colspan=1>12000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>0.1924</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.2321</td><td rowspan=1 colspan=1>5.8</td></tr><tr><td rowspan=2 colspan=1>MCC 2</td><td rowspan=1 colspan=1>I2000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>16.6</td><td rowspan=1 colspan=1>0.4300</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0.4071</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>0.6184</td><td rowspan=1 colspan=1>3.7</td></tr><tr><td rowspan=1 colspan=1>12000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>17.3</td><td rowspan=1 colspan=1>0.4000</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>0.5459</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>1.3228</td><td rowspan=1 colspan=1>7.7</td></tr><tr><td rowspan=2 colspan=1>MCC 3</td><td rowspan=1 colspan=1>I2000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>30.3</td><td rowspan=1 colspan=1>0.8739</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.6784</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>1.1695</td><td rowspan=1 colspan=1>3.9</td></tr><tr><td rowspan=1 colspan=1>I2000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>31.0</td><td rowspan=1 colspan=1>0.6344</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>1.1223</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>1.3178</td><td rowspan=1 colspan=1>4.3</td></tr><tr><td rowspan=2 colspan=1>Serum panel 1</td><td rowspan=1 colspan=1>I2000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.0829</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.1140</td><td rowspan=1 colspan=1>4.0</td></tr><tr><td rowspan=1 colspan=1>12000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.1601</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>0.0835</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.1806</td><td rowspan=1 colspan=1>6.2</td></tr><tr><td rowspan=2 colspan=1>Serum panel 2</td><td rowspan=1 colspan=1>I2000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>39.8</td><td rowspan=1 colspan=1>0.9526</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1.0065</td><td rowspan=1 colspan=1>2.5</td></tr><tr><td rowspan=1 colspan=1>12000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>41.0</td><td rowspan=1 colspan=1>1.0822</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0.4470</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>1.2947</td><td rowspan=1 colspan=1>3.2</td></tr><tr><td rowspan=2 colspan=1>Serum panel 3</td><td rowspan=1 colspan=1>12000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>53.3</td><td rowspan=1 colspan=1>1.7061</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>0.2887</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.7303</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>12000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>55.8</td><td rowspan=1 colspan=1>1.5047</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.9540</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>1.8730</td><td rowspan=1 colspan=1>3.4</td></tr><tr><td rowspan=2 colspan=1>Urine panel 1</td><td rowspan=2 colspan=1>I2000I2000SR</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>0.1270</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>0.0545</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>0.1482</td><td rowspan=1 colspan=1>6.2</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.1636</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0.0463</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>0.1700</td><td rowspan=1 colspan=1>6.4</td></tr><tr><td rowspan=2 colspan=1>Urine panel 2</td><td rowspan=2 colspan=1>12000I2000SR</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>14.5</td><td rowspan=1 colspan=1>0.3927</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.5875</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>15.9</td><td rowspan=1 colspan=1>0.6039</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.3916</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>0.7198</td><td rowspan=1 colspan=1>4.5</td></tr><tr><td rowspan=2 colspan=1>Urine panel 3</td><td rowspan=1 colspan=1>|2000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>36.8</td><td rowspan=1 colspan=1>1.0509</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>0.5742</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>1.3916</td><td rowspan=1 colspan=1>3.8</td></tr><tr><td rowspan=1 colspan=1>12000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>40.6</td><td rowspan=1 colspan=1>1.5605</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>0.3012</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>1.5893</td><td rowspan=1 colspan=1>3.9</td></tr><tr><td rowspan=2 colspan=1>Urine panel 4</td><td rowspan=1 colspan=1>12000</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>49.0</td><td rowspan=1 colspan=1>2.8402</td><td rowspan=1 colspan=1>5.8</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>2.8402</td><td rowspan=1 colspan=1>5.8</td></tr><tr><td rowspan=1 colspan=1>I2000SR</td><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>53.7</td><td rowspan=1 colspan=1>3.1812</td><td rowspan=1 colspan=1>5.9</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>3.1812</td><td rowspan=1 colspan=1>5.9</td></tr></table>

# Interferences

Interference studies were conducted using CLSI Guideline NCCLS EP7-A2: Interference Testing in Clinical Chemistry.

A. Endogenous Substances 1) Serum

<table><tr><td rowspan=1 colspan=1>InterferingSubstance</td><td rowspan=1 colspan=1>InterferentConcentration</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Targetμg/mL</td><td rowspan=1 colspan=1>Mean Recoveryμg/mL</td><td rowspan=1 colspan=1>% Interference</td></tr><tr><td rowspan=2 colspan=1>Bilirubin</td><td rowspan=2 colspan=1>20mg/dL</td><td rowspan=2 colspan=1>3</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>+3.9</td></tr><tr><td rowspan=1 colspan=1>28.4</td><td rowspan=1 colspan=1>29.8</td><td rowspan=1 colspan=1>+4.9</td></tr><tr><td rowspan=2 colspan=1>Hemoglobin</td><td rowspan=2 colspan=1>10g/dL</td><td rowspan=2 colspan=1>3</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>5.2</td><td rowspan=1 colspan=1>-1.9</td></tr><tr><td rowspan=1 colspan=1>29.4</td><td rowspan=1 colspan=1>30.6</td><td rowspan=1 colspan=1>+0.3</td></tr><tr><td rowspan=2 colspan=1>Triglyceride</td><td rowspan=2 colspan=1>2000 mg/dL</td><td rowspan=2 colspan=1>3</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>4.7</td><td rowspan=1 colspan=1>-7.8</td></tr><tr><td rowspan=1 colspan=1>28.8</td><td rowspan=1 colspan=1>27.1</td><td rowspan=1 colspan=1>-5.9</td></tr><tr><td rowspan=2 colspan=1>Total Protein</td><td rowspan=2 colspan=1>10 g/dL</td><td rowspan=2 colspan=1>3</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>11.4</td><td rowspan=1 colspan=1>+4.6</td></tr><tr><td rowspan=1 colspan=1>34.2</td><td rowspan=1 colspan=1>38.7</td><td rowspan=1 colspan=1>+13.2</td></tr><tr><td rowspan=2 colspan=1>Total Protein</td><td rowspan=2 colspan=1>3 g/dL</td><td rowspan=2 colspan=1>3</td><td rowspan=1 colspan=1>8.1</td><td rowspan=1 colspan=1>9.0</td><td rowspan=1 colspan=1>+11.1</td></tr><tr><td rowspan=1 colspan=1>31.4</td><td rowspan=1 colspan=1>29.3</td><td rowspan=1 colspan=1>-6.7</td></tr></table>

# ) Urine

<table><tr><td rowspan=1 colspan=1>% Interferant</td><td rowspan=1 colspan=1>Concentrationof Interferant</td><td rowspan=1 colspan=1>MeanRecoveryEndogenousCortisol only</td><td rowspan=1 colspan=1>%Interference</td><td rowspan=1 colspan=1>MeanRecoveryCortisolSpiked</td><td rowspan=1 colspan=1>%Interference</td></tr><tr><td rowspan=1 colspan=1>UnalteredUrine Control</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>36.9</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Mockspike Control</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>4.6</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>37.9</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Protein</td><td rowspan=1 colspan=1>1000mg/dL</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>-4.1</td><td rowspan=1 colspan=1>38.6</td><td rowspan=1 colspan=1>-4.6</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>5mmol/L</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>37.0</td><td rowspan=1 colspan=1>2.4</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>350mmol/L</td><td rowspan=1 colspan=1>4.6</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>36.3</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>5mmol/L</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>37.6</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>NaCl</td><td rowspan=1 colspan=1>1000mmol/L</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>-2.0</td><td rowspan=1 colspan=1>38.1</td><td rowspan=1 colspan=1>-3.3</td></tr><tr><td rowspan=1 colspan=1>Boric Acid</td><td rowspan=1 colspan=1>1%</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>37.6</td><td rowspan=1 colspan=1>-1.9</td></tr></table>

# B. HAMA

As with any assay employing mouse antibodies, the possibility exists for interference by human anti-mouse antibodies (HAMA) in the sample, which could cause falsely elevated results.

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Native Cortisolug/dL</td><td rowspan=1 colspan=1>Spiked withCortisol ug/dL</td><td rowspan=1 colspan=1>Spiked withcortisol-freeserum ug/dL</td><td rowspan=1 colspan=1>% Recovery</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>4.7</td><td rowspan=1 colspan=1>101.0</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>11.2</td><td rowspan=1 colspan=1>21.8</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>102.8</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>11.5</td><td rowspan=1 colspan=1>21.2</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>98.1</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>13.9</td><td rowspan=1 colspan=1>8.4</td><td rowspan=1 colspan=1>101.5</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>6.6</td><td rowspan=1 colspan=1>11.7</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>19.9</td><td rowspan=1 colspan=1>29.7</td><td rowspan=1 colspan=1>18.6</td><td rowspan=1 colspan=1>100.3</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>18.3</td><td rowspan=1 colspan=1>28.8</td><td rowspan=1 colspan=1>17.9</td><td rowspan=1 colspan=1>99.7</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>9.7</td><td rowspan=1 colspan=1>14.7</td><td rowspan=1 colspan=1>9.4</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>HAMA-1</td><td rowspan=1 colspan=1>8.6</td><td rowspan=1 colspan=1>13.8</td><td rowspan=1 colspan=1>8.5</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>HAMA-2</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>13.5</td><td rowspan=1 colspan=1>8.5</td><td rowspan=1 colspan=1>97.8</td></tr><tr><td rowspan=1 colspan=3>Grand Mean % Recovery</td><td rowspan=1 colspan=1>Acceptance Criteria100±15%</td><td rowspan=1 colspan=1>100.1</td></tr></table>

# C. Rheumatoid Factor (RF)

Ten positive RF patient samples were assayed for cortisol concentration.

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>NativeCortisolug/dL</td><td rowspan=1 colspan=1>Spiked Cortisolug/dL</td><td rowspan=1 colspan=1>Spiked withcortisol-free.serum ug/dL</td><td rowspan=1 colspan=1>% Recovery</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>11.1</td><td rowspan=1 colspan=1>19.4</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>92.4</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>90.9</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>11.0</td><td rowspan=1 colspan=1>20.5</td><td rowspan=1 colspan=1>11.3</td><td rowspan=1 colspan=1>94.0</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>34.0</td><td rowspan=1 colspan=1>41.8</td><td rowspan=1 colspan=1>33.6</td><td rowspan=1 colspan=1>94.8</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>17.3</td><td rowspan=1 colspan=1>24.9</td><td rowspan=1 colspan=1>16.2</td><td rowspan=1 colspan=1>93.3</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>5.4</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>94.0</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>14.1</td><td rowspan=1 colspan=1>21.8</td><td rowspan=1 colspan=1>13.8</td><td rowspan=1 colspan=1>89.7</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>8.6</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>95.6</td></tr><tr><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>23.8</td><td rowspan=1 colspan=1>31.8</td><td rowspan=1 colspan=1>23.4</td><td rowspan=1 colspan=1>93.8</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>13.8</td><td rowspan=1 colspan=1>24.1</td><td rowspan=1 colspan=1>13.1</td><td rowspan=1 colspan=1>102.1</td></tr><tr><td rowspan=1 colspan=3>Grand Mean % Recovery</td><td rowspan=1 colspan=1>Acceptance Criteria100±15%</td><td rowspan=1 colspan=1>94.1</td></tr></table>

# D. Anticoagulants

Studies were conducted to determine the performance characteristics of the assay for both serum and plasma samples containing Cortisol.

The results indicate that there is no significant difference between the recovery of Cortisol in serum or plasma. The collection tubes evaluated show no adverse effects on the recovery of Cortisol, within the experimental error for the spiking study.

A claim for assay application to both serum and plasma samples is thus supported.

# Specificity

Cortisol was spiked into cortisol free human serum at approximately 12ug/dL. Cross reactant stock concentrates were prepared in solvent and spiked into aliquots of the 12ug/dL cortisol serum to achieve cross reactant concentrations of 100 or 1000ug/dL. A control aliquot was prepared for each solvent system by spiking the solvent into the 12ug/dL cortisol serum at the same volume used with the cross reactant stocks.

<table><tr><td rowspan=1 colspan=1>Cross Reactant</td><td rowspan=1 colspan=1>Test concug/dL</td><td rowspan=1 colspan=1>% CrossReactivity</td></tr><tr><td rowspan=1 colspan=1>11-beta-OH-progesterone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>11-deoxycorticosterone</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.1</td></tr><tr><td rowspan=1 colspan=1>11-deoxycortisol</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>2.1</td></tr><tr><td rowspan=1 colspan=1>17-alpha-OH Pregnenolone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.1</td></tr><tr><td rowspan=1 colspan=1>17-OH-progesterone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>6-beta-OH cortisol</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>6-methyl- prednisolone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.1</td></tr><tr><td rowspan=1 colspan=1>Aldosterone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Beclomethasone</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>beta-cortol</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>beta-cortolone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Beta-Estradiol</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>beta-Sitosterol</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Budesonide</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Canrenone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.1</td></tr><tr><td rowspan=1 colspan=1>Corticosterone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>Cortisol-21-glucuronide</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>Dexamethasone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>DHEA</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>DHEA-S</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Estriol</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Estrone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Fludrocortisone</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>36.8</td></tr><tr><td rowspan=1 colspan=1>Fluticasone Propionate</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Medroxy ProgesteroneAcetate</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Mometasone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Prednisolone</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>12.5</td></tr><tr><td rowspan=1 colspan=1>Prednisone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>0.6</td></tr></table>

# On-Board Stability

# Calibration Curve stability

Calibration curve stability of a period of 30 days is supported by the data.

# Reagent On-Board Stability

A 30 day on-board reagent stability claim is supported by the data.

# CONCLUSION

The ARCHITECT Cortisol assay has been shown to be substantially equivalent to the Abbott AxSYM Cortisol assay through the following performance testing: The performance testing verifies that the device functions as intended and that design specifications have been satisfied.

# OCT 1 9 2006

Mr. Jack Rogers   
Manager of Regulatory Affairs Seradyn, Inc.   
7998 Georgetown Rd., Suite 1000 Indianapolis, IN 46268

Re: k062204 Trade/Device Name: ARCHITECT Cortisol Regulation Number: 21 CFR 862.1205 Regulation Name: Cortisol (hydrocortisone and hydroxycorticosterone) test system Regulatory Class: Class II Product Code: JFT, JIT Dated: July 31, 2006 Received: August 3, 2006

Dear Mr. Rogers,

This letter corrects our substantially equivalent letter of 9/22/2006.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specinformation about the aplication beling reqirments  your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its tol-ree number (800) 638-2041 or (301) 443-6597 or at its Intemet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/31a3496d3717c0874ccd1c04e60d72588f546b1f1a544a3afefe336f6bca71f8.jpg)

Alberto Gutierez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): : K062204

Device Name: ARCHITECT Cortisol

# Indications for Use:

ARCHITECT Cortisol is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of cortisol in human serum, plasma or urine on the ARCHITECT / System. The ARCHITECT Cortisol assay is intended for use as an aid in the diagnosis and treatment of adrenal disorders.

The ARCHITECT Cortisol Calibrators are for the calibration of the ARCHITECT i System when used for the quantitative determination of cortisol in human serum, plasma or urine.